校正:子宫内膜癌中的免疫微环境:机制和治疗向
Yilin Wang1,2, Nana Liu1,2, Xiangcui Guo3,2,4
1Xinxiang Medical University, Xinxiang, China.
Frontiers in immunology
|February 12, 2026
概括
这项研究纠正了先前发表的一篇文章的DOI. 修正后的DOI确保了正确的引用和对研究结果的访问.
科学领域:
- 免疫学 免疫学 免疫学
- 科学出版科学出版
背景情况:
- 准确的引用对于科学完整性至关重要.
- 数字物体识别器 (DOI) 对于定位研究文章至关重要.
研究的目的:
- 纠正特定科学文章的数字物体标识符 (DOI).
- 确保研究的准确引用和可访问性.
主要方法:
- 发布了一份纠正通知.
- 正确的DOI被确定并公布.
主要成果:
- 文章的DOI已经更新.
- 读者现在可以使用更正的DOI访问该文章.
结论:
- 校正确保了科学记录的完整性.
- 适当的引用有助于研究成果的传播.
相关概念视频
Distance Corrections
301
To achieve precise distance measurements, especially in surveying and construction, certain corrections must be applied to account for potential sources of error like the standardization errors, temperature variations, and slope adjustments.Standardization error emerges when measurement equipment undergoes changes, such as wear, repairs, or weather impacts. To address this, surveyors compare the equipment’s readings to a standard. This process identifies any deviation that might lead to...
301
What is the Immune System?
132.4K
Overview
132.4K
Humoral Immune Responses
84.1K
Overview
84.1K
Power Factor Correction
557
The power transmission to a factory involves the transfer of apparent power, a combination of active and reactive power. The power factor measures how effectively electrical power is converted into useful work output. The ratio of the real power (KW) that does the work to the apparent power (KVA) supplied to the circuit.
557
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Therapeutic Index
6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K


